Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Projected Valuation Of The Dry Eye Medication Market In The Coming Years?

The market for dry eye drugs has seen rapid expansion in recent years. Projected growth is from $10.96 billion in 2024 to $12.13 billion in 2025, which represents a compound annual growth rate (CAGR) of 10.7%. Several factors have contributed to this historic growth, including an aging population, rise in contact lens wearers, higher disposable income levels, more treatment options, increased allergy incidence, more unhealthy or improper dietary consumption, and prevalence of diabetes mellitus.

The market size for dry eye treatments is projected to witness swift expansion in the forthcoming years. The market value is anticipated to reach “$18.08 billion by 2029”, with a compound annual growth rate (CAGR) of 10.5%. The anticipated growth during the projection period can be credited to factors such as an upsurge in laser surgeries, increased screen time, hectic lifestyles, escalating diabetes prevalence, a rise in instances of dry eye condition, a promising pipeline for the treatment of dry eye disease, and side effects from other drugs. The forecast period is likely to see key trends such as the creation of preservative-free eye drops, investment in the research and development of novel and superior drugs, the development of innovative medications to sustain in the market, the production of non-steroidal anti-inflammatory eye drugs for dry-eye syndrome treatment, an emphasis on integrating contemporary techniques, and the formulation of combined therapies for dry eye disease treatment.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3807&type=smp

Which Factors Are Steering Growth In The Dry Eye Medication Market?

The surge in dry eye disease instances results in greater need for its remedy. Factors such as growing older, vitamin A deficiency, wearing lenses, eye surgeries, exposure to dry wind or smoke, and prolonged screen time make the development of dry eye more probable. For instance, the American Academy of Ophthalmology’s survey identified that almost 3.2 million women and 1.68 million men above 50 years in the US experienced dry eye syndrome. In the same vein, the Indian Journal of Ophthalmology’s research unveiled a 32% presence of dry eye disease in North India. Such escalating incidences of the disease necessitate its cure and thereby expedite the expansion of the dry eye medication market.

What Are The Key Segment Trends Observed In The Dry Eye Medication Market?

The dry eye medication market covered in this report is segmented –

1) By Type Of Product: Aqueous, Evaporative, Aqueous and Evaporative

2) By Delivery System: Liquid, Gel, Ointment, Other Delivery System

3) By Prescription Type: OTC Drugs, Prescription Drugs

4) By End-User: Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Aqueous: Artificial Tears (lubricating eye drops), Prescription Eye Drops, Ophthalmic Solutions

2) By Evaporative: Punctal Plugs (to reduce tear drainage), Lipid-Based Eye Drops, Eye Ointments (with lipid components)

3) By Aqueous and Evaporative: Combination Eye Drops (formulated to address both aqueous And evaporative dry eye), Multi-Action Eye Care Products

Which Disruptive Trends Are Driving Change Across The Dry Eye Medication Market?

Leading businesses in the dry eye treatment market are introducing ground-breaking products like Cyclosporine eye solutions, engineered to encourage tear production, decrease ocular inflammation and offer durable relief. Ophthalmic solutions of Cyclosporine, which are prescription eye drops laden with the immunosuppressant cyclosporine, are mainly employed to counter dry eye disease by augmenting tear production and relieving eye inflammation. To illustrate, in June 2023, the U.S. Food and Drug Administration (FDA) granted approval to Novaliq GmbH, a biopharmaceutical firm based in Germany, for their product VEVYE (cyclosporine ophthalmic solution) 0.1%, specifically designed to alleviate the signs and symptoms of dry eye disease. VEVYE, also known as CyclASol in its developmental phase, is the inaugural and sole cyclosporine solution that has been given the nod for treating dry eye disease symptoms, demonstrating effectiveness in merely a month of treatment. Enhanced with a revolutionary, water-absent excipient, VEVYE caters to patient requirements by offering a rapid, well-accepted remedy for dry eyes. As opposed to regular solutions, it does not contain water, anti-microbial preservatives, oils, or surfactants, thus eliminating issues related to pH and osmolarity.

Who Are The Major Stakeholders Operating In The Dry Eye Medication Market?

Major companies operating in the dry eye medication market include Allergan plc, Alcon Inc., Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd., OASIS Medical, Inc., VISUfarma B.V., Sun Pharmaceutical Industries Limited, Bayer AG, Pfizer, Johnson & Johnson, Daiichi Sankyo, Zhaoke Ophthalmology Pharmaceutical, Vision gain, Implandata ophthalmic products GmbH, The Geuder Group, Novamedika, Aflofarm Farmacja Polska, VUAB Pharma Inc., Herzig Eye Institute, Thomas Eye Group, Alimera Sciences, Eyegate, Neurotech, Opthotech, Eyepoint pharmaceuticals, ReGenTree, LLC, Regenerx Biopharmaceuticals Inc, shire, Gama Vision, Biolab Pharma, Mitotech, Novaliq GmbH, Horus Pharma, Prestige Consumer Healthcare Inc., Azura Ophthamics Ltd, Similasan, Hoya Corporation, Adcock Ingram.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/dry-eye-medication-global-market-report

What Regional Factors Are Accelerating Growth In The Dry Eye Medication Market?

North America was the largest region in the market in 2024. Middle East is expected to be the fastest-growing region in the global dry eye medication market share during the forecast period. The regions covered in the dry eye medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=3807&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model